Loading...
  • meibomian
  • To comparatively analyze conjunctiva proteome changes in ocular surface diseases (OSD) such as dry eye (DE) and meibomian gland dysfunction (MGD) by 2D-Differential in gel electrophoresis (2D-DIGE). (arvojournals.org)
  • The purpose of this study is to measure the change in Tear Osmolarity during the course of the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and differentiate between the two forms of dry eye. (clinicaltrials.gov)
  • The premise of this study is that dry eye disease, specifically tear osmolarity, changes during the course of the day based on the etiology of the dry eye and that aqueous-deficiency dry eye will worsen during the course of the day while meibomian gland deficiency will stabilize or possibly even improve during the course of the day. (clinicaltrials.gov)
  • The measured difference in Tear Osmolarity during the course of the day to support clinical diagnosis and differentiate between aqueous-deficiency and meibomian gland disease. (clinicaltrials.gov)
  • limbal
  • Methods: This student thesis is based on a number of review articles and original articles on PubMed using the search words limbal, limbal stem cell deficiency, conjunctival and/or ocular surface reconstruction. (uio.no)
  • Restasis
  • We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease. (clinicaltrials.gov)
  • The purpose of this study is to determine whether Restasis is an effective treatment for preventing the occurrence and progression of dry eye syndrome in patients who have recently received a bone marrow transplant and are at risk to graft-versus-host disease. (clinicaltrials.gov)
  • patients
  • The purpose of this study is to evaluate the tolerability and preliminary efficacy of DNase eye drops in patients with Sjogren's and Non-Sjogren Dry Eye Disease. (clinicaltrials.gov)
  • visual
  • It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. (clinicaltrials.gov)